Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
61 studies found for:    Open Studies | "Alopecia"
Show Display Options
Rank Status Study
21 Recruiting "Impact of Chemotherapy-induced Alopecia on the Quality of Life of Women With Breast Cancer"
Condition: Chemotherapy-induced Alopecia
Intervention: Behavioral: Semi-structured interviews
22 Recruiting Scalp Cooling to Prevent Chemo-induced Hair Loss
Conditions: Breast Cancer;   Alopecia
Interventions: Device: PAXMAN Orbis Scalp Cooler;   Other: Control No treatment
23 Not yet recruiting Study to Assess the Efficacy of Intralesional Corticosteroid on the Treatment of Frontal Fibrosing Alopecia
Condition: Frontal Fibrosing Alopecia
Intervention: Other: Corticosteroid/Saline
24 Not yet recruiting Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment
Condition: Androgenetic Alopecia
Interventions: Device: Autologous Platelet Rich Plasma;   Device: Saline solution injection
25 Recruiting Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Condition: Alopecia
Interventions: Drug: setipiprant;   Drug: placebo;   Drug: finasteride
26 Recruiting LEO 124249 Ointment in the Treatment of Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: LEO 124249;   Other: Vehicle
27 Not yet recruiting Safety and Efficacy Study of SHAPE Gel in Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: SHAPE Gel
28 Recruiting TREg Activation in the Treatment of the PELADE (Alopecia Areata)
Condition: Alopecia Areata
Interventions: Drug: IL2;   Drug: placebo
29 Unknown  Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: Interleukin-2
30 Unknown  Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss - Alopecia Areata
Condition: Alopecia Areata
Interventions: Device: Subcutaneous injection luer syringe;   Device: DERMOJET (a syringe without a needle)
31 Recruiting Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention: Device: topical 5% Minoxidil (Microneedling)
32 Recruiting Treatment of Androgenetic Alopecia in Males With Theradome™ LH80 PRO
Condition: Androgenetic Alopecia
Interventions: Device: LH80 PRO;   Device: Sham Device
33 Not yet recruiting Safety and Efficacy Study of Hairstetics' ANCHORING SYSTEM For Hair Extensions For Subjects Affected With Hair Thinning
Condition: Alopecia, Androgenetic
Intervention: Device: Hairstetics™ anchoring system
34 Unknown  Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Device: PRGF-Endoret;   Other: Saline Solution
35 Recruiting Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females
Condition: Alopecia Areata
Intervention: Other: MEXIS/M6S Patent - lotion against alopecia
36 Unknown  The Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Zinc Supplement
Condition: Female Pattern Alopecia
Interventions: Drug: 15 mg Chelate zinc supplement;   Drug: Placebo drug supplement
37 Unknown  24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness
Condition: Androgenetic Alopecia
Interventions: Device: iRestore Hair Rejuvenation System;   Device: sham device
38 Not yet recruiting Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil
Conditions: Female Pattern Hair Loss;   Androgenetic Alopecia
Interventions: Drug: 5% Topical Minoxidil Solution;   Drug: 15% Topical Minoxidil Solution
39 Unknown  Safety and Efficacy of Nitric Oxide Gel in Promoting Hair Growth in Male Human Subjects With Androgenetic Alopecia
Condition: Alopecia Androgenica
Interventions: Other: Nitric Oxide (NO) Gel;   Other: Placebo gel
40 Not yet recruiting Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic Alopecia
Condition: Androgenic Alopecia
Interventions: Drug: DA-4001 H;   Drug: DA-4001 L

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years